After Sony’s Spider-Man: Into the Spider-Verse and Across the Spider-Verse, the studio is now developing an animated film for its second most popular Marvel Comics character, Venom. THR reports that Zach Lipovsky and Adam B. Stein are attached to direct the upcoming film.
Lipovsky and B. Stein’s most recent film was the long-awaited sixth installment in the Final Destination franchise, titled Final Destination: Bloodlines. The Warner Bros. Pictures film was made on a $50 million budget and grossed over $317 million.
THR also confirmed that the live-action Venom actor, Tom Hardy, will be involved in the upcoming film. While it is not clear whether he will only serve as a producer or voice the titular character, Eddie Brock.
How Sony’s Animated Spider-Man Films Have Fared on the Box Office?
While Sony’s attempt at a live-action Spider-Man universe was a miserable failure, they have been quite successful with the animated Spider-Verse film. From the genius mind of Phil Lord, the first two Spider-Verse films are two of the best superhero films ever made.
Revolving around Miles Morales’ Spider-Man, the first animated Spider-Man film titled Into the Spider-Verse came out in 2018, and it made a whopping $394 million on a budget of $90 million. Its sequel came out in 2023, and it was titled Across the Spider-Verse, and it made over $690 million on a budget of $100-$150 million. The last film in the Spider-Verse trilogy is set to release in June 2027 and is titled Across the Spider-Verse.
How did the Live Action ‘Venom’ Trilogy Fared at the Box Office?
The first live-action Venom film was directed by Ruben Fleischer and grossed over $856 million on a budget of $100- $116 million. Its sequel, titled Venom: Let There Be Carnage, was released in 2021 and directed by Andy Serkis. It was also made on a budget similar to the first film, but unlike the 2018 film, it only made over $506 million.
The last film in the Venom trilogy, titled Venom: The Last Dance, came out in 2024. It was written and directed by Kelly Marcel, and it was the least profitable film in the trilogy, earning only $478.9 million.